Cargando…
Toxoplasmosis complications and novel therapeutic synergism combination of diclazuril plus atovaquone
Toxoplasmosis is a major cause of foodborne disease, congenital complication, and morbidity. There is an urgent need for safe and effective therapies to encounter congenital and persisting toxoplasmosis. The hypothesis was: combination diclazuril plus atovaquone to exert a novel therapeutic synergy...
Autor principal: | Oz, Helieh S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164033/ https://www.ncbi.nlm.nih.gov/pubmed/25309522 http://dx.doi.org/10.3389/fmicb.2014.00484 |
Ejemplares similares
-
Diclazuril Protects against Maternal Gastrointestinal Syndrome and Congenital Toxoplasmosis
por: Oz, Helieh S., et al.
Publicado: (2014) -
Atovaquone ameliorate gastrointestinal Toxoplasmosis complications in a pregnancy model
por: Oz, Helieh S., et al.
Publicado: (2012) -
Maternal and congenital toxoplasmosis, currently available and novel therapies in horizon
por: Oz, Helieh S.
Publicado: (2014) -
Toxoplasmosis, Pancreatitis, Obesity and Drug Discovery
por: Oz, Helieh S.
Publicado: (2014) -
Safety and efficacy of Coxiril(®) (diclazuril) for pheasants
por: Rychen, Guido, et al.
Publicado: (2018)